Back to Search
Start Over
A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer.
- Source :
- Clinical Breast Cancer; Jun2014, Vol. 14 Issue 3, p154-160, 7p
- Publication Year :
- 2014
Details
- Language :
- English
- ISSN :
- 15268209
- Volume :
- 14
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Clinical Breast Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 96156822
- Full Text :
- https://doi.org/10.1016/j.clbc.2013.12.012